Nikaia Pharmaceuticals

Develops small-molecule NIK inhibitors for cancer and autoimmune disease treatment

+ Add to sales board

Highlights

  • Young companyFounded 2024
  • New on EvolcAdded 2026-11-09

About Nikaia Pharmaceuticals

Nikaia Pharmaceuticals is developing selective small-molecule inhibitors of NF-κB-inducing kinase (NIK), a regulator of the non-canonical NF-κB pathway. Its research targets cancer, including melanoma, and autoimmune diseases.

The company was founded in 2024 and is based in Nice, France. It is completing preclinical development of an oncology candidate and expanding its autoimmune disease pipeline.

Product: Small-molecule NIK inhibitors in preclinical development for cancer and autoimmune diseases.

Jobs at Nikaia Pharmaceuticals

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Noraker

    Develops and manufactures resorbable biomaterial implants for surgeons treating bone defects and supporting bone regeneration
    Lyon, FranceBiotech & pharmaFounded 2005
    New on Evolc
  • Nordic Pharma

    Specialty pharmaceutical company marketing licensed prescription products to doctors and patients in France
    Paris, FranceBiotech & pharmaFounded 1998
    New on Evolc
  • Norgine

    Pharmaceutical products and European commercialization partnerships for patients and healthcare systems
    Rueil-Malmaison, FranceBiotech & pharmaFounded 1955
    New on Evolc
  • Novalix

    Preclinical drug discovery services for biotechnology and pharmaceutical companies
    Strasbourg, FranceBiotech & pharmaFounded 20022 open jobs
    New on Evolc
  • Novaptech

    Custom aptamer development, assays and biosensors for biotechnology, pharmaceutical, academic and agri-food organizations
    Gradignan, FranceBiotech & pharmaFounded 2016
    New on Evolc
  • Novo Nordisk

    Pharmaceutical company making diabetes, obesity and rare disease medicines and injection pens for patients in France
    Puteaux, FranceBiotech & pharmaFounded 2003
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content management

  • SquarespaceHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.